The Leadership Team at Hopstem drives the company’s strategic vision and operational execution in the pharmaceutical sector. Comprising the CEO and Chief Business Officer, the team focuses on fostering innovation in human iPSCs/ESCs neural differentiation, advancing cell banking solutions, and enhancing cell engineering initiatives to ensure market competitiveness and sustainable growth.
View all